United States Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032

United States Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A2986

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   United States Hospital Acquired Disease Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Indication
    6.1    UTI (Urinary Tract Infection)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    SSI (Surgical Site Infection)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Pneumonia
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Bloodstream Infections
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    MRSA (Methicillin-Resistant Staphylococcus Aureus)
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Region
    7.1    Northeast
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Midwest
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    South
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    West
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   SWOT Analysis
    8.1    Overview
    8.2    Strengths
    8.3    Weaknesses
    8.4    Opportunities
    8.5    Threats
9   Value Chain Analysis
10  Porters Five Forces Analysis

    10.1    Overview
    10.2    Bargaining Power of Buyers
    10.3    Bargaining Power of Suppliers
    10.4    Degree of Competition
    10.5    Threat of New Entrants
    10.6    Threat of Substitutes
11  Policy and Regulatory Landscape
12  Competitive Landscape

    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players

List of Figures

Figure 1: United States: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
Figure 2: United States: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2018-2023
Figure 3: United States: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: United States: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2023
Figure 5: United States: Hospital Acquired Disease Testing Market: Breakup by Region (in %), 2023
Figure 6: United States: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 7: United States: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 8: United States: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: United States: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: United States: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: United States: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: United States: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: United States: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: United States: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: United States: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: United States: Hospital Acquired Disease Testing (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: United States: Hospital Acquired Disease Testing (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Northeast: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Northeast: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Midwest: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Midwest: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: South: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: South: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: West: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: West: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: United States: Hospital Acquired Disease Testing Industry: SWOT Analysis
Figure 27: United States: Hospital Acquired Disease Testing Industry: Value Chain Analysis
Figure 28: United States: Hospital Acquired Disease Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: United States: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2023 and 2032
Table 2: United States: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 3: United States: Hospital Acquired Disease Testing Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 4: United States: Hospital Acquired Disease Testing Market: Competitive Structure
Table 5: United States: Hospital Acquired Disease Testing Market: Key Players

United States Hospital Acquired Disease Testing Market Report by Indication (UTI (Urinary Tract Infection), SSI (Surgical Site Infection), Pneumonia, Bloodstream Infections, MRSA (Methicillin-Resistant Staphylococcus Aureus), and Others), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials